Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific cellular "switches" that drive tumor...
Search results for "k-bio"
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion
Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan. By combining the foundational research and technical...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009
Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors
When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
Global Asset Managers Expand Holdings in South Korean Pharma and Biotech
Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and...
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation
Staff supporting biohealth research and development (R&D) spend substantial time navigating and analyzing massive...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...